1-1 of 1
Marius Erik Mayerhoefer
Close
Sort by
Journal Articles

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma

Clinical Trials & Observations
Barbara Kiesewetter, Ella Willenbacher, Wolfgang Willenbacher, Alexander Egle, Peter Neumeister, Daniela Voskova, Marius Erik Mayerhoefer, Ingrid Simonitsch-Klupp, Thomas Melchardt, Richard Greil, Markus Raderer
Journal: Blood
Blood (2017) 129 (3): 383–385.
https://doi.org/10.1182/blood-2016-06-720599
Published: 2017